First patient receives low-dose psilocybin in rare headache disorder trial
Phase Ib trial is evaluating the potential benefit of low-dose psilocybin as a treatment for SUNHA - News - PharmaTimes
Source: pharmatimes.com
Stay updated with breaking news from Manjit Matharu. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phase Ib trial is evaluating the potential benefit of low-dose psilocybin as a treatment for SUNHA - News - PharmaTimes